In T2DM patients, pathogenic bacterial overgrowth is frequently associated with elevated serum levels of D-lactic acid and intestinal fatty acid-binding protein (I-FABP), biomarkers indicative of compromised intestinal barrier function (44). This evidence concerns the gene FABP2 and type 2 diabetes mellitus.